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Glycoprotein lila CGP lila) is a platelet membrane receptor. which when activated leads to platelet 
adhesion. Platelet alloantigen <P1Al is normally represented on the GPIIIa of human platelet membrane 
in the more common homozygous allelic state CP1A1/A1l. or the rarer polymorphic state CP1A1/A2l. The 
. later polymorphism P1A1/A2 polymorphic state renders the platelet hyperadhesive leading to increased 
incidence of coronary events and possibly migraine as well. Migraine is also a disorder wherein platelet 
hyperadhesion and serotonin release have been observed. Migraine is a common headache disorder 
exhibiting a prevalence of 9% in the Malaysian population. 
This study was designed to identify the prevalence of the homozygous CP1A1/A1l and the polymorphic 
CP1A1/A2) state in the population at Kelantan and to determine whether the polymorphic state 
CP1A1/A2l is more common in our migraine patients. So far no work has been published from Malaysia 
on this subject. 
A case control study was conducted between September 2004 and October 2005. eightv (80) patien(s 
who fulfilled the International Headache Society (IHSl criteria for migraine with or without aura. and a 
group of eighty healthy volunteers were recruited for the study. The P1A1/A2 genotype pattern of all 
these 160 individuals was analysed by polymerase chain reaction CPCRl using the Allele Specific 
Oligonucleotide CASO) technique and the results compared with the nigraine symptoms in the patients 
concerned. 
·It was found that 77 (of the 80) controls and 76 (of the 80lcases with migraine possess the homozygous 
(P1A1/P1A1l configuration. indicating that in the population here the homozygous state is more 
common (i.e present in 153 out of 160 individulas studied). Secondly. the occurrence of the P1A1/A2 
polymorohism in only four (of the 80) migraine cases and also three (of the 80) controls suggest that the 
polymorphic CP1A 1/A2) state is not more frequent in the migraine cases. Thirdly. of the four cases 
positive for P1A1/A2 polymorphism three had classical visual aura (75%). 
Earlier studies have reported that migraine with aura has an increased familial incidence when 
compared with migraine without aura suggesting that migraine with aura could well be related to the 
inheritance of this P1A1/A2 polymorphism state. 
Although our findings do not totally support the hypothesis that the P1A2 polymorphism represents an 
added inherited platet risk factor for migraine or even migraine with aura. further searches for such a 
factor are clearly warrwnted. because of the familial aggregation of migraine headache cases. 
Thus this preliminary study shows that P1A1/A2 polymorphic state on the GPIIIa platelet membrane 
receptor does not increase the risk of inheriting migraine. However if present it is more likely to manifest 
as migraine with aura in the migraineurs with this polymorphism. 
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mainly a study to verify the hypothesis of the P1A1/P1A2 polymorphism and its influence on 
migraine. based on the platelet behaviour. However. certain observations that could prove 
beneficial are : understanding the link between the genetics and the clinical presentation of 
the migraine syndrome and development of newer drug for treatment of migraine (especially 
those with aura) based on the presence or absence of P1A2 polymorphism. In any case. this 
study has been the first of its kind to bring to light the P1A1/P1A2 status in Kelantan 
population. 
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ABSTRAK 
Glikoprotein IDa ialah membran platelet yang. hila diaktifkan, menyebabkan adhesi 
platelet. Alloantigen platelet (PIA) pada kebiasaannya berada pada GPilla membrane 
platelet dalam keadaan yang homozigus aiel ( PlAI/ AI) ataupun sebahagian kecil berada 
dalam status polimorphisma (PIA1/A2). Status polimorphisma (PIA1/A2) menyebabkan 
platelet menjadi terlebih adhesive menyebabkan peningkatan penyakit koronari dan juga 
kemungkinan dalam migrin. Migrin ~ah penyakit dimana adhesi platelet meningkat 
dan rembesan serotonin berlaku .. 
Migrlti adalah sejenis ~t kepala yang lazim berlaku dengan prevalen sebanyak 9% 
dalam populasi Malaysia. 
Kajian ini dirangka untuk mengenalpasti prevalen homozygis (PIAl/At) dan status 
polimorphisma (PIAI/A2) dikalangan penduduk di Kelantan dan untuk mengenalpasti 
sama ada polim.orphisma (PIA1/A2) adalah Iebih kerap dalam penyakit migrin. Setakat 
ini tiada kajian sebegini yang telah diterbitkan di Malaysia dalam subjek ini. 
Satu kajian kes control telah dijalankan dari September 2004 dan Oktober 2005. Lapan 
puluh pesakit yang memenuhi criteria persatuan sakit kepala internasional (lliS) bagi 
migrin dengan aura dan migrin tanpa aura, disamping itu juga sekumpulan Iapan puluh 
orang sukarelawan telah masukkan didalam kajian ini. 
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Corak genetik PIAl/ A2 bagi kesemua 160 orang individu telah dianalysi menggunakan 
teknik "PCR'' dan "Allele Specific Oligonucleotide (ASO)" dan keputusannya 
dibandingkan dengan simptom pesakit terlibat . 
Adalah dijumpai bahawa 77 (dari 80) control dan 76 (dari 80) kes migrin mempunyai 
konfigurasi homozigus (PlAl/Al), ·menll~Yukkan dalam populasi ini status homozigus 
adalah lebih kemp ( dalam 153 daripada 160 individu yang dikaji). · 
Keduanya, polimorphisma PIAl/ A2 berlaku dalam 4 kes ( dari 80) migrin dan 3 ( dari 80) 
control menunjukkan status polimorphisma (PIA1/A2) tidak berlaku dengan lebih kerap 
dalam kes migrin. 
Ketiganya, bagi keempat - empat kes yang positif untuk PIA1/A2 menpunyai simptom 
aura visual (75%). Kajian terdahulu mendapati babawa pesakit migrin dengan aura 
insidennya meningkat di kalangkan keluarga hila banding dengan migrin tanpa aura 
menunjukkan migrin dengan aura mungkin berkait dengan status polimorphisma 
PIA1/A2. 
Walaupun keputusan kajian ini tidak menyokong sepenuhnya hipotesis dim.ana 
polymorphisma PIA2 menyebabkan peningkatan risiko platelet kepada pesakit . migrin 
dengan aura. Penyelidikan lanjut adalah diperlukan, kerana terdapat pesakit keluarga bagi 
sakit kepala jenis migrin. 
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Jadi kajian ini mendapati status polimorphisma PIAl/ A2 bagi GPIIIa reseptor membrane 
platelet telah meningkatkan risiko mengbadap~ ~JPin,. walaubagaimanapun jika ada 
Ianya adalah lebih ber~tan dengaii migrin Q.engan aura dikalangan pesakit migrin 
dengan polymorphisma ini. 
XV 
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ABSTRACT 
Glycoprotein llia (GP illa) is a platelet membnirie receptor, which when activated leads 
to platelet adhesion. Platelet alloantigen (PIA) is· normally represented on the ~Pilla of 
human platelet membrane in the more ·common homozygous allelic state (PIAl/ AI), or 
the rarer polymorphic state (PlA1/A2). The latter polymorphic PIA1/A2 polymorphic 
state renders the platelet hyperadhesive leading to increased incidence of coronary events 
. . 
and possibly migraine as well. Migraine is also a disorder wherein platelet hyperadhesion 
and serotonin release have been observed. Migraine is a common headache disorder 
eXhibiting a prevalence of 9~ in the Malaysian population. 
This study was designed to identify the prevalence of the homozygouS (PIA~/ AI) and the 
polymorphic (PIA1/A2) state in the population at Kelantan and to detennine whether the 
polymorphiG state (PlAt+A2}·ismore COlllDl61l in our migraine patients. So far no work 
has been published from Malaysia on this subject. 
A·case control study was conducted between September 2004 and October 2005. Eighty 
(80) patients who fulfilled the International Headache Society (IHS) criteria for migraine 
with or without ~ura, and a group of eighty healthy volunteers wete recruited for the 
study. The PIA1/A2 genotype pattern of all these 160 individuals was analysed by 
polymerase chain reaction (PCR) using the Allele Specific Oligonucleotide ·(ASO) 
technique and the results compared with the migraine symptoms in the patients 
concerned. 
xvi 
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It was found that 77 (of the 80) controls and 76 (of the 80) ·cases with migraine possess· 
the homozygous (PIAl/PIAl) configuration, ~~c~g that in the population here the 
homozygous.state is more common (i.e presen~ in 153 out of 160 indiviuals studied). 
. . 
Secondly, the occurrence of the PJAl/ A2 polymorphism in only four (of the 80) migraine 
cases and also three (of the 80) ~ontrols suggest that the polymorphic (PIAl/ A2) state is 
not more frequent in the migraine cases. Thirdly, of the four cases positive for PIAl/ A2 
polymorphiSm three· had classical visual ama (75%). 
Earlier studies have reported that migraine with aura has an increased familial incidence 
when compared with migraine without aura suggesting that migraine with aura could well 
be related to the inheritance of this PIA1/A2 polymorphic state. 
Although our findings do not totally SUJ?port the hypothesis ~t the PIA2 polymorphism 
~----· ------ ------ -
- ~--- ---~---
represents an added inherited platelet risk factor for migraine or even migraine with aura, 
further searches for such a factor are clearly warranted, because of the familial 
aggregation of migraine headache cases. 
Thus this preliminary study shows that PIAl/ A2 polymorphic state on the GPIDa platelet 
membrane receptor does not increase the risk of inheriting migraine. However if present, 
it is more likely to manifest as migraine with aura in: the migraineurs with this 
.·polymorphism. 
xvii 
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1.0 Introduction 
1.1 Migraine: a complex disease 
Migraine is a common disabling disorder characterized by the recurrence of painful and 
at times non ... paitiful episodic phenomena associated with a variety of neurologi~ 
· manifestations. _It ranks among the top 20 causes of disability worldwide (Stewart WF 
et at., 1999). 
Migraine may be considered as a chronic illness (migraine seen ~ a. 'disease') 
· interspersed with acute s_igns and symptoms (migraine seen as an 'attack'). Migraine is , 
characterized by a great variability of phenotypic expressions. 
The clinical heterogeneity of migraine involves both the attacks and the disease. 
Another important aspect of the heterogeneity is the significant association between 
migraine and other neurological diseases (epilepsy, episodic ataxia, cerebrovascular 
disorders, mitochondrial diseases), psychiatric illnesses (anxiety, mood and personality 
disorders), and cardiova8cular disorders (arterial hypertension, mitral valve proiapse) 
(Nappi G et al., 2000). The co-morbidity of migraine, may be the result of genetic 
factors such as the presence of different mutations in the same gene (allelic disease) or 
mutations in genes located on neighbouring segments of the same chromosome 
(Ducros A et al., 2002) 
1 
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1.2 Prevalence and frequency of migraine· 
Migraine is a highly prevalent headache ~sorder that has a substantial impact on 
individuals and on society. Migraine is now ranked by the World Health Organization 
as the number 19th among all diseases c~ing disability (Jes Oleson et al., 2003). One-
year migraine pre-Valence· in the general population for Western countries varieS from 
4% to 9% iD. ~en and 11% to 25% in women (Lipton RB et al., 2001). 
A community based study on headaches in Malaysia showed the prevalence of 
migraine to be 9 % in the population (Alders EE et al., 1996). Migraine has been found 
to be two to three times more prevalent in women than in men (Lipton RB et al., 2001 ). 
Migraine prevalence has also been found to be· age-dependant In children, the 
l!~~~n~ of migraine increases with age," with niale preponderance before puberty 
and female p~ponderance thereafter (Lipton RB et al., 2001 ). In adults, the prevalence 
of migraine in women increases with age peaking at the fourth and· fifth decade after 
which it declines. A similar trend is seen with males. The effeet of gender on migraine 
prevalence may be only partially explained by hormonal factors because gender 
difference persists after the menopause (Pascual J et al., 2001 ). 
Migraine has been shown to be common in all races but significantly higher in 
Caucasians, when migraine prevalence ~ been studied in African Americans or Asian 
Americans. These data suggest that race- related differences cannot be explained only 
by cultural and environmental factors and that a different genetic vulnerability may be 
2 
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important. Several lines of evidence supports that genetic factors are involved -in 
migraine, especially in migraine with ~ura . ~m~ with migraine without attra · 
(Russel MB and Olesen J, 1995). Studies of ~amilial aggregation have revealed that 
first-degree relatives of probands who had migraine with ama had a four-fold increased 
risk of migraine with aura. The most likely mode of inheritance is multifactorial 
(Russel MB and Olesen J, 1995). 
1.3 Pathophysiology of migraine 
The mechanisms underlying migraine have not been fully understood. Several theories 
have been proposed on the pathogenesis of migraine which are: the vascular theory, the 
cortical spreading depression theory, the neurovascular hypothesis and the brainstem ' 
"migraine generator" theory. 
1.3.1 The Vascular Theory 
The vascular theory, as proposed in 1938 by Graham and Wolff attributes migraine to 
an initial intra-cranial arterial vasoconstriction, resulting in ischemi~ to the visual 
cortex and symptoms of aura, followed by a period of extra-cranial vasodilatation 
resulting in the throbbing headaches (Wolff HG, 1938). It has been pointed out by 
subsequent workers time and again, that the entire syndrome of migraine cannot be 
explained merely on the basis of vascular constriction and dilatation only. 
3 
1.3.2 The Cortical Spreading Depression Theory 
This neuronal theory of Cortical Spreading Depression (CSD) observed initially by 
Leao (Leao AAP, 1944) envisages an electrical phenomenon. CSD is a relatively short-
lasting wave of depolarization that originates from the cerebral cortex and spreads. 
across the surface of the brain, usually moving from the back (occipital region) of the 
ipsilateral .cereb~ cortex toward the front and laterally at about 3-6 mm/minute 
• • • • I 
(Lauritzen M, 1994). According to the theory, CSD begins with a brief wave of 
excitation, followed by a prolonged period of neuronal depression, which is associated 
with disturbances in nerve cell metabolism and regional reductions in blood flow. This 
disturbance spreading along the visual cortex causes the initial flickering phenomenon 
during the irritative phase and then leads on to the scotoma representing the depressed 
neuronal function phase. Similarly, sensory aura in the form of tingling on the surface 
-, ---.. -of die body has also been observed in some cases of migraine. Clinical observations, 
neuro-imaging techniques and blood flow measurements clearly indicate CSD to be the 
primary underlying factor for the aura and not cerebral ischemia as was previously 
thought (Cutrer FM et al., 1998). 
1.3.3 The Neurovascular Hypothesis 
The neuro-vascular theory implicates the trigemino-vascular neural network as the 
major pain-signalling system, wherein the perivascular trigeminal axon tenninals 
release antidromically certain neuropeptides (including substance P, neurokinin A, 
calcitonin gene-related peptide (CGRP and others) during the migraine attacks 
resulting in neurogenic inflammation causing vasodilatation, mast cell degranulation, 
4 
increased platelet aggregation and alterations in the vascular permeability. This 
neurogenic inflammation leading to the ce~~ _ ~sion of pain impulses is 
believed to cause the migraine headache phen~menon. 
1.3.4 The Brain stem "migraine generator" theory 
The dorS~ raphe nucleus in the peri-aqueductal gray matter in the brainstem has ~gh 
concentration of serotonin which happens to be an important central neurotransmitter. 
This nucleus also contains serotoninpsecreting neurons whose axons ~~e on 
cerebral blood vessels and various other brain areas· that are involved in the production 
of migraine symptoms. It has thus been suggested that the raphe nucleus, which is 
sensitive to the changes in blood serotonin levels, may serve as a "migraine generator", 
(Curran DA et al., 1965) leading on to the cascading of the migraine syndrome. The 
demonstration of persistent brainstem activation during and after an attack of migraine 
as imaged in Positron emission topography (PEn scans lends support to this theory 
(Cutrer FM et al., 1998). 
1.3.5 Current Concept of Migraine - Genetic basis 
All the four theories listed above have their own merits and serve to explain some, if 
not the entire migraine syndrome. Migraine being a common problem, with many 
people in the world being disabled with hea~he, enormous literature on the 
understanding and treatment of the condition continues to be accumulated. 
5 
IV. 
Genetic epidemiology has shown that the risk to first-degree relatives of pro bands with 
migraine with aura is fomfold, whereas in -~~e without aura it is only 1.9 fold, 
clearly indicating that. genetic influence is ~nger in migraine with aura (Russell MB 
et al., 1996). However no clear cut mutation on any particular chromosome has been 
detected. On the contrary, familial hemiplegic migraine patients have been shown to 
have abnormal mutations in the brain-specific P/Q type calcium channel alpha lA 
. . 
subUnit gene· (CACNAlA) on chromoso~~ 19p13 (Joutel A et al., 1993). Abnormal 
mutations are now being postulated which can open up newer therapeutic strategies in 
the prophylaxis and trea1ment of migraine. Thus the role of genetic predisposition to 
migraine is becoming more and more established and this seems to be an ~rtant 
prerequisite in the genesis of migraine. It stands to ·reason therefore that genetic work 
undertaken to study the DNA of ~e migraine patients with aura is more likely to yie}d 
interesting results than in those without the aura. 
The simplest way to explain theSe peculiarities of migraine is to consider the basic 
mechanism as a genetic abnormality resulting in a lowered response threshold of the 
central nervous system (CNS) to specific trigger factors determining the initiation of 
migraine attack. In this model, the trigger factors are considered as modulators of 
genetic set-point that predisposes the individual to migraine. This inabilitY ~o handle 
migraine trigger factors results in a primary CNS dysfunction that secondarily activates 
headache pain. The sequence of events can be schematically represented as shown in 
Figure I. 
6 
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Genetic predisposition 
ffrigger Factol"SJ + 
. Channelopathy . 
! 
Central neuronal hyper~xcitability 
Cortical Spreading Depression (CSD) 
Brainstem activation 
! 
tfrigeminal vascular activatioij 
! 
(Migraine headach~ 
Figure 1 Genetic predisposition to migraine 
Adapted from Handbook of Headache by Randolph W. Evans 2005 
7 
•' 
It appears that Cortical Spreading Depression (CSD) is the first instrumentally 
recordable phenomenon in the migraine cas~~· !he_ CSD probably gets triggered by 
many extraneous factors including hormo~ tf:iggers (menstruation, ovulation and 
pregnancy), dietary triggers (alcohol, chocolates,cheese), psychological triggers, 
environmental triggers (glare, obnoxious. odours), lack of sleep and certain drugs 
(Oestrogens, reserpine, nitroglycerine). 
The triggered CSD leads to excitation of the trigeminal vascular afferents directly 
which is followed by vasodilatation of the dural and pial blood vessels and the large 
blood vessels of the brain. The dilated blood vessels in turn stimulate the netve 
endings which release neuropeptides such as calcitonin-gene related peptide (CGRP), 
substance-P and neurokinin-A. These further dilate the blood vessels and cause a local ,. 
~~Jl]_.-n~tory reaction (plasma extravasation and mast cell degradation) that transduce 
pain at the trigeminal nerve endings (first order neurons). Activation of the trigeminal 
vascular system is the primary mechanism of pain in migraine (Evans RW and Mathew 
NT, 2005). 
Activated first order trigeminal neurons then transmit pain impulses to the second order 
neurons in the trigeminal nuclei which interconnects with the various other brainstem 
nuclei including the nucleus solitarius resulting in nausea and vomiting. (Goadsby PJ, 
1997). 
8 
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The second order trigeminal neurons transmit the pain impulses ros1rally to ·the 
thalamus where the third order neurons take over and convey.the n~ciceptive and other 
. - .. . 
impulses to the cortex, ultimately resultin~. in_ the other later symptoms like 
photophobia, p~onophobia, osmophobia, allodynia, impaired cogDition and attention 
and hyperirritability· 
The upper· brainstem nuclei, apart from housing the migraine generators, have !et 
another role to play in modulating the upward transmission of the pain impulses by 
decreasing the firing rate of the serotonergic cells. 
1.4 Platelets, Serotonin and Migraine 
Observations that both plasma and platelet levels of serotonin fluctuate during a 
migraine attack suggest that serotonin may be involved in the pathogenesis of 
migraine. When platelets are activated, they aggregate and release seroto~ thus 
increasing the plasma serotonin level. This increase in plasma serotonin level leads on 
to initial vasoconstriction; and the subsequent depletion and abrupt fall in the serum 
serotonin level results in intense rebound vasodilatation manifested clinically as the 
throbbing headaches. Platelet serotonin levels have been observed to drop precipitously 
during the headache phase of migraine. Also, the urine levels of serotonin and its 
:;~ metabolites rise suggesting that there had been a large release of serotonin into the 
~} 
~· 
plasma during such attacks. The changes in plasma serotonin levels also reflect the 
more importan~ disturbances in brain serotonin levels. 
9 
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The tendency of platelets to get easily activated leading to hyperaggregation has been 
adequately documented in migraineurs _(~o~ch J.R and R.S., 1976). The platelets of_ 
migraine patients are more sensitive ~ in normal individuals in their response to 
several vasoactive.amines, including serotonin, catecholamine and tyramine (KovacK 
et al., 1990). 
Secondly,. ·platele~ contain over 90 percent of the serotonin (5-hydroxytryp~e, 5-
HT) in the blood. At the onset of an attack of migraine a significant rise in the plasma 
concentration of serotonin has been observed (Dvilansky A et al., 1976). Even during 
the headache-free periods, migraine patients were shown to exhibit greater degrees of 
platelet sensitivity to serotonin and adenosine diphosphate than healthy controls 
(Lechner H et al., 1985). The work of Sicuteri and associates and Curran &td 
colleagues also confirmed the role of serotonin and its metabolites during all phases of 
a migraine attack. These investigations demonstrated that serotonin-releasing agents. 
can induce niigraine-like attacks. The fact that many of the newer drugs used for 
management of acute migraine are serotonin receptor agonists further highlights the 
fact that serotonin is a key player in migraine pathogenesis. The various serotonergic 
mechanisms of migraine are summarized in Figure_ 2. 
10 
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Abnormal discharge of neurons in the brain stem (Activation of 
. . . .. 
trigeminovascular nerve) 
l 
Perivascular 
inflammation 
l 
l 
I Prostaglandin, Kinin I release . 
! 
Sensitization of nerve 
endings. 
l 
Excitation of nerve 
terminals. 
l 
PAIN 
l 
1 
I Vasodilatation 
1 
I Nonadrenallile neurons activation ! . 
I Cerebial Vasoconstriction 
l 
I Visual disturbances 
Figure 2 Serotonergic mechanisms of migraine in the CNS 
Adapted from Migraine Headache - An Update by H. S. Mahajan et al 2004 
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5HT is a transmitter in the central nervous system and· present in high concentration in 
localized region of the mid~ Certain eve~~ o~ su~stances can set off an imbalance 
of naturally occurring chemicals in the brain, .causing the blood vessels of the head to 
expand. The area around these blood vessels becomes inflammed and irritates nerve 
endings. This dilation and irritation may account for the throbbing pain. 
It m~ finally be pomted out that though much bas been written on platelets, serotonin 
and migraine, the exact 'inter-relationship between the following key observations in 
cases of migraine has not been fully worked out. They may well be independent of one 
another and not causally related (i.e) platelet dysfunction of hyperaggregability and 
increased sensitivity to vaso-active amines in patients with migraine and activation of 
the serotonergic neurons at the brainstem level during attacks. 
Still, the co-existence of the above factors noticed in cases of migraine points out to 
some hitherto unexplored association. 
1.5 Physiology of platelet function 
1.5.1 Platelet Adhesion, Aggregation and Thrombus formation 
Platelet activation leads to adhesion and can be initiated by several mechanical and 
chemical stimuli. Platelet aggregation with subsequent thrombus formation is the k~y 
event in the development of acute coronary syndromes and sudden death of patients 
with coronary heart disease (Chesebro rn:., 1992). 
12 
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Platelet adhesion is triggered by damage to the vessel wall and local exposure to the 
subendothelial matrix. Coverage of the ~~sed site by platelets de~nds on the 
recognition of ~esive proteins by specific platelet-membrane glycoproteins, many of 
which are intergrlns (Hynes RO, 1987, Smyth SS et al., 1993). 
Integrins are found on virtually all cells and they mediate many different physiologic 
responses .. 1?-e maj~r integrins present on the surface of platelets are listed in Table 1 
and all of them have been shown to play a part in the process of platelet adhesion. 
Several receptors, each with distinct functions are involved in the process of thrombus 
formation. These include glycoprotein (GP) lb-IX-V complex, the integrins a2Pt and 
a5(31 (Savage Bet al., 1998) and platelet GP VI. As a result of these initial interactions, 
~ platelet is activated, leading to a change in another integrin, «llbfu which contnbutes. to 
t~:. 
~f the homotypic aggregation of platelet into a thrombus. The first receptor to be 
h 
~· 
~~· scrutinized was the integrin «nbP3 (initially designated glycoprotein llb-illa), the most 
\ 
" 
abundant receptor on the platelet membrane surface. 
The rate of platelet activation is the important variable that contributes to either 
beneficial or adverse outco~es. In view of their key role in thrombosis, it is natural to 
wonder whether polymorpbisms in platelet receptors can influence the risk of 
cardiovascular disease. In the last few years, there has been a rapid accumulation of 
literature concerning the relationship between genetic variations in platelet . 
glycoproteins and risk for coronacy artery disease. Since the initial report by Weiss et 
al in 1996, that PIA2 polymorphism is a cardiovascular risk factor, no fewer than 17 
13 
.. 
studies have presented findings on this topic. Of these, nine support a role for the PIA2 
allele as a thrombotic risk factor, and eight do not (fatiana V et al., 2000). 
. . . . 
r:!: 
a'· ~: [ The underlying platelet hyperaggregability and vascular involvement as observed in the 
~, pathophysiology of migrame suggests the plausibility of an association between 't. 
~;.' ~ migraine and coronary heart disease (CHD). However the literature is inconclusive on 
~K ~ ~ this ~ject.. Populati~-based studies report both an increased occurrence of CliD 
r . among migrainems (Mitchell p et al., 1998) as well no association between the two ~~ 
~; 
1'!. 
t• 1~;> illnesses (Cook NR et al., 2002). 
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fl Table 1 
Platelet-Membrane Glycoprotein Receptors involved in the 
Adhesion and Aggregation of Platelets. 
Receptor 
Integrin 
a2p1 (glycoprotein 
I~a) 
a5f31 (glycoprotein 
Icllla) 
aDbP3 (glycoprotein 
llb/IIIa) 
Nonintegrin 
Glycoprotein Ib 
Gl co rotein IV 
Ligand 
Collagen 
Fibronectin 
Laminin 
Fibrinogen 
Fibronectin 
von Willebrand factor 
Vitronectiil 
Vitronectin 
Fibrinogen 
Fibrqnectin 
von Willebrand factor 
von Willebfand factor 
Thrombospondin 
Collagen 
Receptor- Mediated 
Action 
Adhesion 
Adhesion 
Adhesion 
Aggregation 
Adhesion 
Adhesion 
Adhesion 
Adapted from Platelet glycoprotein llb/Illa receptors in cardiovascular medicine 
Jeffrey Lefkovits et a11995 
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l.S.2 Structure and Function of the GP llb-llla Receptor 
The human platelet membrane glycoprotein · (GP) llb-illa complex (integrin anbf33) 
m~ates platelet aggregation via the binding of adhesive· proteins, such as :fibrinogen 
and von Willebrand factor (vWF) (Phillips et al., 1988)~ 
The GPIIbfi;IIa rec~tor consists of a 2-chain glycoprotein llb subunit noncovalently 
. . 
associated with a single-chain glycoprotein Illa subunit (Figure 3). Its 136-kd a 
subunit consists of a h~vy chain and a light chain. The 92-kd P subunit consists of a 
·single polypeptide of 762 amino acids. Of the eight P integrin subunits, the allb subunit 
has been found only in combination with {13, mostly in cells of the megakaryocyte 
lineage. The subunits are noncovalently bound to each other, and to fibrinogen, von 
Willebrand factor, fibronectin, vitronectin, and a number of other adhesive proteins 
. . resulting in hetemdimers-(Lefk:ovits et al., 1995). 
The genes encoding glycoprotein lib and rna are located on chromosome 17q21 
~~. (Thornton MA et al., 1999). Integrins are receptor proteins that promote interactions 
m between cells and their environment and 'they also act as cellular sensors and signaJJing 
it 
~. :~\ molecules. Integrins are found virtually on all cells and mediate many different 
::~ 
i 
., physiologic responses . 
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,...- Glycoprotein ltb 
(« subunit) 
COOH CO~ Cytoplasmic tair 
Figure 3 Diagram of Platelet Glycoprotein Ilblllla Receptor 
NH2 denotes the amino group, COOH the carboxyl group, and S the disulfide group. 
Adapted from Plow et a1 1992 
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·~ t. ~':- Three allelic variants of the integrin subunit allb have been defined which differ at 
!i-: 
~ either residue 837 (Val or Met) (Noris P et. ~., _ 19~5) or residue 843 (Ser or lle) 
~ (Lyman s et al., 1990). Eight different alleles of the P3 can be distinguished which 
~ differ at six positions within the coding sequence. These dimorphic residues and their 
serologic designations include Leu33/Pro33 (HPA-1a/HPA-lb) (Newman PJ et al., 
1989). The molecular b.asis of this polymorphism is a thymine-cytosine change at 
position 15.65 ·in ·exon 2 of the GPIIIa gene (also known as integrin P3-ITGB3 ge~e) 
(Reiner A et al., 2001). Amino acid substitutions in platelet membrane glycoprotein 
result in alloantigens. As a result human platelet alloantigen (HPA-la or PIAl) 
molecules have a leucine, whereas HP A-1 b or PIA2 proteins have a proline, at position 
33 of the mature P3 integrin chain (Newman PJ et al., 1989). These inherited 
po1ymorphisms within the platelet membrane glycoprotein genes can alter their , 
antigenicity, regulate their expression levels and modulate their functional properties. 
s Shulman NR et al had shown that the PIA system was the first recognized platelet-
specific alloantigen implicated in neonatal alloimmune thrombocytopenia (NAIT) and 
matemofetal incompatibility for PIA antigens accounts for more than 90 % of reported 
cases ofNAIT as well as most cases of post transfusion purpura (Mueller-Eckhardt C 
et al., 1989). Recent studies done on GPIIIa gene have shown that possession of an A2 
allele increases the tendency for platelet adhesion and hence the risk for myocardial 
infarction (Weiss EJ et al., 1996) (Anderson JL et al., 1999) coronary artery disease 
(Gardemann A et al., 1998) and restenosis after stent placement (Kastrati A et al., 
. 1999) 
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The platelet GPITblllia receptors have an important role in thrombus formation 
(Lefkovits et al., 1995). Platelet activati~~ c~use~ changes in the shape of platelets and 
conformational changes in glycoprotein . ITb!IIIa receptors, transforming the receptors 
from a ligand-unreceptive to a ligand-receptive state. Ligand-receptive glycoprotein 
lib/Ilia receptors bind fibrinogen molecules, which form bridges between adjacent 
platelets and facilitate platelet aggregation. Inhibitors of glycoprotein ITb!ITia receptors 
~ also bind to. glycoprotein !Ibniia receptors, blocking the binding of fibrinogen and thus 
~ · preventing platelet aggregation (Figure 4). 
Several point mutations in the genes that encode GPllb and GPIIIa result in disorders 
of platelet binding. As techniques tq identify mutations in the genes encoding these 
glycoproteins have become available, interest has grown in the possibility that some of 
these mutations may represent independent risk factors for vascular thrombosis. The 
smdy-by Weiss and colleagues had suggested that the platelet GPllia polymorphism 
PIAl/ A2 is an important inherited risk factor for acute coronary ischaemia 
In their retrospective case-control study, patients with coronary thrombosis were more 
likely than controls to carry the PIA2 allele, especially those who were 60 years or 
younger at the time of infarction. Since the estimated frequency of the PlA2 allele 
among northern and central Europeans is 15%, (S Simsek, 1993), this inherited defect 
of platelet ·binding could contribute substantially to the pathogenesis of thromboses. 
This discovery has opened up novel therapeutic approaches with treatment and 
prevention trials using GPllbffila inhibitors; and attempts to identify high-risk 
subgroups are also being made (Coller BS, 1995). 
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Agonist 
. Adenolinll 
·GPtl~llla­
receplllr 
ootagonlst ~ 
. .J, filii'- . 
· c[iphcnphale, throrrbin. 
epinophme, and cth!r.i 
Resting platelet 
GP llblllla reeep~ in 
ligltnd-unreceplive ttale 
Aotlvated platelet 
GP llb'llla raceplors in 
ligand-receptive Illata 
Inhibition of 
platelet aggregation 
GP lib' lila receptol'$ occupied 
by:antlgorisl 
Aggregating platelets 
GP llblllla reccpt<n 
o::cupied by fibrinogen. 
wljch ilrms bridges 
between adj9Cefll pbltelels 
Figure 4 Overview of the Processes of Platelet Activation and Aggregation. and 
the lnhibition of Platelet Aggregation by Inhibitors of GP Db/IDa 
Receptors. 
Adapted from Platelet glycoprotein Ilbiiiia receptors in cardiovascular medicine 
Jeffrey Lefkovits et al 1995 
20 
. ., 
.. 
" 
6 Principles of Polymerase Chain Reaction (PCR) 1. 
The Polymerase Chain Reaction (PCR) in mo~ecular study permits the selective in vitro 
amplification of a particular DNA region with a pair of oligonucleotide primers (Saiki 
. . 
R et al., 1988). As a result a million fold of pr9ducts are produced. The essential 
components for PCR amplifica~on are; 
i) the strands of a DNA double helix run in an opposite polarity along 
the backbone, such that one strand is viewed as extending in the 5' 
to 3' direction, the other strand runs in the 3' to 5' direction; 
ii) a target sequence in a DNA sample that lies between the pair of 
primers and can be form 100 to - 35,000 base pair in length; 
iii) a thermostable DNA polymerase that can withstand heating to 95°C · 
or higher; 
iv) oligonucleotides of about 15-17 bases will normally hybridize to a 
unique site on a DNA. 
A PCR reaction consists of a number cycles for amplifying a specific DNA 
sequence. Each cycle has three successive steps; denaturation, annealing and 
synthesis. In the first step of a PCR reaction, the DNA is denatured by heating to 
93°C to 95°C so that the strands come apart. In the second step the reaction is 
cooled to a lower temperature, typically 50-72°C such that the primers anneal 
selectively to the regions which flank the target site to be amplified. Lastly, the 
reaction is heated to 72°C to 75°C and the DNA polymerase extends the primers 
21 
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such that a copy of the target region is synthesized. Typically, this three steps 
sequence is repeated for 25 to 35 cycl~ .. 
The elegant technique of PCR, by which fragments of DNA can be made to 
replicate very rapidly, is illustrated in Figure 5 . 
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POL YMERRSE CHHI N RERCTI JJN 
Jjiillpiiill.iiii@, 
!Hiiill!il I hj 1"\1!t 
primer 
2. 
Another round: DNA is 
denatured, primers are 
attached, and the 
number of DNA 
strands are doubled. 
s. 
1. . . . 
DNA is denatured. Primers attaCh · 
t o each strand. A new DNA strand 
is synthesized behind primers on 
each template str.and. 
Jijijfiijij!ijeiji ilif 
3, 
Another round: DNA 
is denatur~ primers 
are attache~ and the 
number of DNA 
strands are doubled. 
Ji (@ "'t! •8J& 
e 
•~a 
.l!lli!i!f 
4. 
Another round: DNA is 
denatured, primers 
are attache~ and the 
number of DNA 
strands are doubled. 
Continued rounds of amplification swiftly produce 
large numbers of identical fragments. Each 
fragment contains the DNA region of interest. 
Figure 5 The PCR cycle sequence 
'*' iiiiiii'i!;Qik 
&lgfi. 
H®Kir 
a:Will 
l4ttXIM 
m:ta 
Jt~ 
Adapted from Access Excellence @ the National Health Museum Copyright 1999 
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Commonly, oligonucleotides of about 20 nucleotides long are used as primers. 
Primers should not contain a sequ~~ ~th any internal secondary structW'es, 
especially at the 3' end because the o~gonucleotide may not anneal properly. In 
addition the primers should not be able to hybridize to each other in order to avoid 
the synthesis of primer dim.ers. With any primer it is desirable to confum that the 
sequence is not found in other parts of the genome (Saiki R et al., 1988). The G C 
. . . 
·content of the primer will affect the reaction temperature. It is therefore desirable to 
make the G C contents of the two primers similar. 
The reaetion condition for each experiment may vary and has to be optimized to 
obtain the best results. The annealing temperature must be low enough to get 
sufficient annealing to start the PCR reaction, but high. enough to prevent 
nonspecific priming. The optimum reaction conditions often differ for different 
DNA polymerases and different PCR machines (Innis MA et al., 1990). 
1.6.1 Methods for detection of PIAl/PIAl genotypes 
Detection of P1Al/A2 polymorhism can be carried out by various methods. Two 
main approaches have been used for platelet genotyping, both based on PCR 
technique: allele specific oligonucleotide (ASO) hybridization (McFarland JG et 
al., 1991 ~ and digestion PCR-amplified material with restriction endonucleases 
(restriction fragment length polymorphism; RFLP) (Newman PJ et al., 1989). 
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